Tolga Tanguler - 01 Oct 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler
Issuer symbol
ALNY
Transactions as of
01 Oct 2025
Net transactions value
-$635,126
Form type
4
Filing time
03 Oct 2025, 17:14:03 UTC
Previous filing
02 Sep 2025
Next filing
14 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tanguler Tolga EVP, Chief Commercial Officer 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler 03 Oct 2025 0001849458

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +2,851 +11% $0.000000 28,843 01 Oct 2025 Direct F1
transaction ALNY Common Stock Sale $24,559 -55 -0.19% $446.53 28,788 02 Oct 2025 Direct F2, F3
transaction ALNY Common Stock Sale $12,094 -27 -0.09% $447.92 28,761 02 Oct 2025 Direct F2, F4
transaction ALNY Common Stock Sale $38,594 -86 -0.3% $448.77 28,675 02 Oct 2025 Direct F2, F5
transaction ALNY Common Stock Sale $53,525 -119 -0.41% $449.79 28,556 02 Oct 2025 Direct F2, F6
transaction ALNY Common Stock Sale $117,211 -260 -0.91% $450.81 28,296 02 Oct 2025 Direct F2, F7
transaction ALNY Common Stock Sale $71,846 -159 -0.56% $451.86 28,137 02 Oct 2025 Direct F2, F8
transaction ALNY Common Stock Sale $144,408 -319 -1.1% $452.69 27,818 02 Oct 2025 Direct F2, F9
transaction ALNY Common Stock Sale $71,242 -157 -0.56% $453.77 27,661 02 Oct 2025 Direct F2, F10
transaction ALNY Common Stock Sale $53,216 -117 -0.42% $454.84 27,544 02 Oct 2025 Direct F2, F11
transaction ALNY Common Stock Sale $15,954 -35 -0.13% $455.82 27,509 02 Oct 2025 Direct F2, F12
transaction ALNY Common Stock Sale $32,020 -70 -0.25% $457.43 27,439 02 Oct 2025 Direct F2
transaction ALNY Common Stock Sale $458 -1 -0% $457.64 27,438 02 Oct 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2024, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of thirty (30) percent of the shares subject to the PSU based on the issuer publicly reporting the initiation of a Phase 3 clinical study in a prevalent indication, as determined by the People, Culture and Compensation Committee of the Issuer Board of Directors on October 1, 2025.
F2 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of PSUs granted to the reporting person on March 1, 2024.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $446.19 to $447.19. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $447.21 to $448.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $448.25 to $449.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $449.26 to $450.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $450.29 to $451.29. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $451.31 to $452.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $452.33 to $453.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $453.37 to $454.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $454.38 to $455.34. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $455.42 to $456.09. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.